Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    JICC01 - Joint IASLC-CAALC-CSCO Session: The Truth and Myth of Oral Anti-VEGFR Inhibitors for Advance NSCLC

    • 07:00 - 09:00
    • 1/28/2021
    • Location: Scientific Program Auditorium
    • Not for CME Credit
    • Type: Workshop
    • Track: N.A.
    • +

      JICC01.01 - Chair

      07:00 - 07:00  |  Presenter: Yi-long Wu

      • Abstract

      No abstract available for this presentation

    • +

      JICC01.14 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy

      08:40 - 08:45  |  Presenter: Qing Zhou

      • Abstract

      Loading...

  • +

    IS06 - Industry Symposium Sponsored by Novartis: Novel Frontiers in the Treatment of NSCLC

    • 15:30 - 16:30
    • 1/28/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS06.01 - Welcome and Introduction

      15:30 - 15:30  |  Presenter: Yi-long Wu

      • Abstract

      No abstract available for this presentation

    • +

      IS06.02 - Evolution of the NSCLC Treatment Landscape

      15:30 - 15:40  |  Presenter: Yi-long Wu

      • Abstract

      No abstract available for this presentation

    • +

      IS06.07 - Closing

      16:29 - 16:30  |  Presenter: Yi-long Wu

      • Abstract

      No abstract available for this presentation

  • +

    PL01 - Opening Plenary Session (Japanese, Mandarin, Spanish Translation Available)

    • 18:00 - 20:00
    • 1/28/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL01.01 - Chair

      18:00 - 18:05  |  Presenter: Yi-long Wu

      • Abstract

      No abstract available for this presentation

  • +

    FP01 - Early Stage/Localized Disease

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Early Stage/Localized Disease
    • +

      FP01.03 - Genetic Predisposition for Pre-Invasive Lung Adenocarcinoma Manifesting as Ground-Glass Nodules with Family History of Lung Cancer

      00:00 - 00:00  |  Presenter: Rui Fu

      • Abstract

      Loading...

  • +

    FP13 - Immunotherapy (Phase II/III Trials)

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      FP13.04 - KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC

      00:00 - 00:00  |  Presenter: Byoung Chul Cho

      • Abstract

      Loading...

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • +

      FP14.09 - Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial

      00:00 - 00:00  |  Presenter: Rémi Veillon

      • Abstract

      Loading...

    • +

      FP14.12 - Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK–Positive NSCLC Patients: eXalt3.

      00:00 - 00:00  |  Presenter: Yi-long Wu

      • Abstract

      Loading...

    • +

      FP14.17 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy

      00:00 - 00:00  |  Presenter: Qing Zhou

      • Abstract

      Loading...

  • +

    P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
    • +

      P01.16 - Tamoxifen Might Enhance the Effect of EGFR-TKIs on EGFR-Mutant NSCLC Cells

      00:00 - 00:00  |  Presenter: Yun-Ting He

      • Abstract

      Loading...

  • +

    P56 - Tumor Biology and Systems Biology - Basic and Translational Science - CT DNA

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P56.01 - Postoperative ctDNA Positive Presents the High-risk of Recurrence in Resectable Non-Small Cell Lung Cancers

      00:00 - 00:00

      • Abstract

      Loading...

  • +

    P59 - Tumor Biology and Systems Biology - Basic and Translational Science - Genomics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P59.03 - Intratumoral Heterogeneity and Clonal Evolution in Large Non-Small Cell Lung Cancer (>7cm) Delineated by Multiregion Sequencing

      00:00 - 00:00  |  Presenter: Jia-Tao Zhang

      • Abstract

      Loading...

    • +

      P59.04 - Sex-Related Differences in Genomic and Immune Profiling of Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Xue-Tao Li

      • Abstract

      Loading...

  • +

    P72 - Tumor Biology and Systems Biology - Basic and Translational Science - Tumor Microenvironment

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P72.02 - Cellular Landscape of Tumor Immune Microenvironment and Genetic Signatures Identify Prognostic of LUAD

      00:00 - 00:00  |  Presenter: Si-Yang Liu

      • Abstract

      Loading...